Thrombophilia cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
Aditya Govindavarjhulla (talk | contribs)
Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Thrombophilia}} ==References== {{reflist..."
 
update
Line 1: Line 1:
__NOTOC__
__NOTOC__
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{Thrombophilia}}
{{Thrombophilia}}
{{CMG}}  {{AE}} {{asiri}}
==Thrombophilia cost-effectiveness of therapy==
*It is important to determine which patients require [[Thrombophilia_screening|screening]] for thrombophilia, and subsequently which patients require [[Thrombophilia_medical_therapy|treatment]].
*Certain [[Thrombophilia_history_and_symptoms|clinical scenarios]] may warrant [[Thrombophilia_screening|thrombophilia screening]].
*Unnecessary thrombophilia screening can lead to increased costs.


==References==
==References==

Revision as of 05:30, 16 July 2016

Thrombophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombophilia cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombophilia cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombophilia cost-effectiveness of therapy

CDC on Thrombophilia cost-effectiveness of therapy

Thrombophilia cost-effectiveness of therapy in the news

Blogs on Thrombophilia cost-effectiveness of therapy

Directions to Hospitals Treating Thrombophilia

Risk calculators and risk factors for Thrombophilia cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]

Thrombophilia cost-effectiveness of therapy

References

Template:WH Template:WS